MacroGenics | MGNX - Profitto Lordo Sulle Vendite

Prezzo Delle Azioni
2.86
Cambio Giornaliero
-0.04 -1.38%
Mensile
63.43%
Annuale
43.36%
Q1 Previsione
2.77




Profitto Lordo Sulle Vendite Cambiamento Data
AbbVie USD 10.47B 605M 2025-09
Amgen USD 6.48B 307M 2025-09
AstraZeneca USD 12.39B 5M 2025-12
Biogen USD 1.65B 34.6M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Genmab DKK 977M 13M 2025-12
Geron USD 46.71M 525K 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
J&J USD 16.6B 118M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
MacroGenics USD 31.11M 30.14M 2025-12
Merck USD 13.42B 431M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Xencor USD 21M 22.61M 2025-09